Molecular descriptors that influence the amount of drugs transfer into human breast milk

Journal of Pharmaceutical and Biomedical Analysis

Volumn 29, Issue 1-2, 2002, Pages 103-119

  Agatonovic Kustrin, S ^a   Ling, L H ^b   Tham, S Y ^b   Alany, R G ^c  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

ANNs; GA; Milk to plasma ratio; Molecular descriptors; QSAR; QSPR

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; AMFEBUTAMONE; AMITRIPTYLINE; AMOXICILLIN; AMPHETAMINE; AMPICILLIN; ASTEMIZOLE; ATENOLOL; BUPIVACAINE; CANNABIS; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CARBENICILLIN; CEFALEXIN; CEFOTAXIME; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL; CHLORPROTHIXENE; CIMETIDINE; CIPROFLOXACIN; CITALOPRAM; CLEMASTINE; CLOMIPRAMINE; CLONAZEPAM; CODEINE; COTININE; DIAZEPAM; UNINDEXED DRUG;

ARTICLE; ARTIFICIAL NEURAL NETWORK; BREAST MILK; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG INFORMATION; DRUG MILK LEVEL; DRUG STRUCTURE; FEMALE; GEOMETRY; HUMAN; MOLECULAR SIZE; PHYSICAL CHEMISTRY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM CHEMISTRY; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS; VALIDATION PROCESS;

ANIMALS; HUMANS; INTESTINAL ABSORPTION; MILK, HUMAN; NEURAL NETWORKS (COMPUTER); PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037142350     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00037-7     Document Type: Article

References (163)

1. Adverse effects of drugs and chemicals in breast milk on the nursing infant
2. Drugs and breastfeeding
3. Neuroleptic drugs in breast-milk: A study of pharmacokinetics and of possible adverse effects in breast-fed infants
4. Psychotropic medications in lactation
5. Active transport of cimetidine into human milk
6. Active transport of nitrofurantoin across the mammary epithelium in vivo
7. Active transport of nitrofurantoin across a mouse mammary epithelial monolayer
8. Drug use during breast-feeding
9. Adverse effects of drugs and chemicals in breast milk on the nursing infant
10. Prediction of drug transfer into human milk based on molecular structure descriptors
11. Partitioning and lipophilicity in quantitative structure-activity relationships
12. Estimating diffusion-coefficients of dense fluids
13. Comparison of parameters currently used in the study of structure-activity relationships
14. Computer-assisted rational design of immunosuppressive compounds
15. Molecular diversity and its analysis
16. Quantification of molecular shape and its correlation with physico-chemical properties
17. Generalization of topological indices
18. Sertraline and desmethylsertraline in human breast milk and nursing infants
19. Breastfeeding and sertraline: A 24-hour analysis
20. Alcohol and breastfeeding
21. Possible effect of lactational period on the milk-to-plasma drug concentration ratio in lactating women: Results of an in vitro evaluation
22. Can chronic maternal drug therapy alter the nursing infant's hepatic drug metabolizing enzyme pattern?
23. Acyclovir excretion in human breast milk
24. Transfer of aciclovir from plasma to human breast milk
25. Antidepressant treatment during breast-feeding. Review
26. Secretion of amitriptyline and metabolites into breast milk
27. Amitriptyline in human breast milk and nursing infant's serum
28. Amitriptyline excretion in human milk
29. Clinical pharmacokinetics in pregnancy and perinatology. II. Penicillins. Review
30. Amphetamine secretion in breast milk
31. Blood and milk concentrations of ampicillin in mothers treated with pivampicillin and in their infants
32. Excretion of drugs in human breast milk
33. Aspirin in breast milk
34. Salicylate excretion in breast milk
35. Drug distribution in human milk
36. Atenolol in human plasma and breast milk
37. Accumulation of atenolol and metoprolol in human breast milk
38. Excretion of lidocaine and bupivacaine in breast milk following epidural anesthesia for cesarean delivery
39. Excretion of bupropion in breast milk
40. Caffeine secretion into breast milk
41. Caffeine in human milk and in serum of breast-fed infants
42. Presence of delta9-tetrahydrocannabinol in human milk
43. Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance liquid chromatography
44. Carbamazepine: Placental transport, tissue concentrations in foetus and newborn, and level in milk
45. Transfer of antibiotics into maternal milk
46. Breast feeding and antibiotics
47. Levels of cefotaxime in body fluids and tissues: A review
48. Transmammary passage of cefoxitin: Additional results
49. Ceftriaxone distribution and protein binding between maternal blood and milk postpartum
50. Passage of cephalosporins and amoxicillin into the breast milk
51. Excretion of chloramphenicol in human milk
52. Presence of chlorprothixene and its metabolites in breast milk
53. Pharmacokinetics of cimetidine during lactation: Species differences in cimetidine transport into rat and rabbit milk
54. Cimetidine excretion into breast milk
55. Active transport of cimetidine into human milk
56. Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast-fed infant
57. Citalopram and demethylcitalopram in human milk; Distribution, excretion and effects in breast fed infants
58. Drug utilization in breast-feeding women
59. Serum clomipramine and metabolite levels in four nursing mother-infant pairs
60. Neonatal apnea associated with maternal clonazepam therapy: A case report
61. Clonazepam in breast milk
62. Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk
63. Codeine and the breastfed neonate
64. Nicotine and cotinine concentrations in serum and milk of nursing mothers
65. Excretion of loratadine in human breast milk
66. Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infant's serum
67. Excretion of imipramine and desipramine in human breast milk
68. Excretion of doxepin and N-desmethyldoxepin in human milk
69. Studies on the excretion of diazepam and nordazepam into milk for the prediction of milk-to-plasma drug concentration ratios
70. Excretion of diazepam and its metabolites in human milk during withdrawal from combination high dose diazepam and oxazepam
71. Excretion of diltiazem in human milk
72. Excretion of disopyramide in human breast milk
73. Disopyramide and its N-monodesalkyl metabolite in breast milk
74. The excretion of dothiepin and its primary metabolites in breast milk
75. Ethanol and acetaldehyde in the milk and peripheral blood of lactating women after ethanol administration
76. Transfer of alcohol to human milk
77. Ethosuximide pharmacokinetics in a pregnant patient and her newborn
78. Ethosuximide in human milk and in plasma of a mother and her nursed infant
79. Drug distribution in human milk
80. Distribution and excretion of fluoxetine and norfluoxetine in human milk
81. Gentamicin excretion and uptake from breast milk by nursing infants
82. Haloperidol secreted in breast milk
83. Haloperidol excretion in human milk
84. Ibuprofen in human milk
85. Clinical pharmacokinetics of ibuprofen. The first 30 years
86. Excretion of indomethacin in breast milk
87. Transfer of labetalol into amniotic fluid and breast milk in lactating women
88. Lamotrigine in pregnancy and lactation: A case report
89. Excretion of lorazepam into breast milk
90. The influence of medroxyprogesterone on the duration of breast-feeding in mothers in an urban community
91. Excretion of mefloquine in human breast milk
92. Transfer of mepindolol to newborns by breast-feeding mothers after single and repeated daily doses
93. Methadone distribution and excretion into breast milk of clients in a methadone maintenance programe
94. Methadone levels in breast milk
95. Secretion of methotrexate into human milk
96. Alpha-methyldopa disposition in mothers with hypertension and in their breast-fed infants
97. Atenolol and metoprolol. A comparison of their excretion into human breast milk
98. Metronidazole in breast milk
99. Blood and milk concentrations of metronidazole in mothers and infants
100. Metronidazole excretion in human milk and its effect on the suckling neonate
101. Mexiletine in human blood and breast milk
102. Minoxidil in breast milk
103. Plasma and human milk concentrations of moclobemide in nursing mothers
104. The elimination of morphine and quinine in human milk
105. Morphine excretion in breast milk and resultant exposure of a nursing infant
106. Nadolol in human serum and breast milk
107. Distribution and excretion of sertraline and N-desmethylsertraline in human milk
108. Nefopam excretion in human milk
109. Determination of nicotine concentrations in human milk
110. Nitrendipine in human plasma and breast milk
111. Nitrofurantoin excretion in human milk
112. Nortriptyline treatment of breast-feeding women
113. Serum nortriptyline levels in nursing mothers and their infants
114. Excretion of noscapine in human breast milk
115. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk
116. Excretion of diazepam and its metabolites in human milk during withdrawal from combination high dose diazepam and oxazepam
117. Excretion of oxazepam in breast milk
118. Excretion of oxprenolol and timolol in breast milk
119. Disposition of acetaminophen in milk, saliva, and plasma of lactating women
120. Excretion of paracetamol in human breast milk
121. Paroxetine in human breast milk and nursing infants
122. Excretion of paroxetine into breast milk
123. Paroxetine in human milk
124. Active transport of benzylpenicillin across the blood-milk barrier
125. Perphenazine in breast milk and serum
126. Analgesic drugs in breast milk and plasma
127. Primidone and phenobarbital during lactation period in epileptic women: Total and free drug serum levels in the nursed infants and their effects on neonatal behavior
128. Factors affecting the milk-to-plasma drug concentration ratio in lactating women: Physical interactions with protein and fat
129. Phenytoin excretion in human breast milk and plasma levels in nursed infants
130. Pharmacokinetics of prednisolone transfer to breast milk
131. Entry of prednisone into human milk
132. Procainamide excretion in human milk
133. Propranolol in breast milk
134. Propranolol in human plasma and breast milk
135. Excretion of quazepam into human breast milk
136. Quinapril and its metabolite quinaprilat in human milk
137. The excretion of rosaramicin in breast milk
138. Pharmacokinetics of roxithromycin
139. Sotalol as a hypotensive agent in pregnancy
140. Excretion of sotalol in breast milk
141. Sertraline and breast-feeding
142. Sertraline in paired blood plasma and breast-milk samples from nursing mothers
143. Distribution and excretion of sumatriptan in human milk
144. Suprofen concentrations in human breast milk
145. Excretion of temazepam in breast milk
146. Breast milk distribution of theobromine from chocolate
147. Theophylline secretion into breast milk
148. Excretion of tiapamil in breast milk
149. Tinidazole milk excretion and pharmacokinetics in lactating women
150. Tolmetin in breast milk
151. Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers
152. Valproic acid in breast milk: How much is really there?
153. Verapamil and norverapamil in plasma and breast milk during breast feeding
154. Vigabatrin: Placental transfer in vivo and excretion into breast milk of the enantiomers
155. Zolpidem excretion in breast milk
156. Monitoring of zonisamide in human breast milk and maternal plasma by solid-phase extraction HPLC method
157. The excretion of zopiclone into breast milk